Published in
BioMed Central, Retrovirology, S3(6), 2009
DOI: 10.1186/1742-4690-6-s3-o25
Links
- ORCID
- BioMed Central | PDF
- [www.retrovirology.com] | PDF
- [www.hal.inserm.fr] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.hal.inserm.fr] | PDF
- [www.hal.inserm.fr] | PDF
Tools
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial
Journal article published in 2009 by
Dominique Salmon-Céron,
Angé la Jackson,
Christine Durier,
Corinne Desaint,
Lise Cuzin,
Mathieu Surenaud,
Yvette Hénin,
Jean-Daniel Lelièvre 
,
B. Bonnet,
Gilles Pialoux,
Isabelle Poizot-Martin,
Nadine Ben Hamouda,
Angéla Jackson,
C. Flys,
Christine Guérin
and other authors.
,
B. Bonnet,
Gilles Pialoux,
Isabelle Poizot-Martin,
Nadine Ben Hamouda,
Angéla Jackson,
C. Flys,
Christine Guérin
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
No abstract available.